tiprankstipranks
Loblaw Companies (TSE:L)
TSX:L
Want to see TSE:L full AI Analyst Report?

Loblaw Companies (L) AI Stock Analysis

1,025 Followers

Top Page

TSE:L

Loblaw Companies

(TSX:L)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
C$68.00
▲(11.13% Upside)
Action:Reiterated
Date:06/05/26
The score is driven primarily by solid financial performance—healthy margins and strong free cash flow—tempered by meaningfully higher leverage. Technicals are supportive but mixed across timeframes, while valuation is a notable headwind due to a higher P/E and low dividend yield.
Positive Factors
Strong cash generation
Sustained operating cash flow (~$6.3B) and robust free cash flow (~$4.4B; ~71% of net income TTM) provide durable internal funding for capex, debt servicing, share actions and reinvestment in omnichannel capabilities, reducing reliance on external financing over the medium term.
Negative Factors
Elevated leverage
Leverage materially above peers for a defensive retailer reduces financial flexibility and increases sensitivity to rate moves. Higher debt burdens can constrain strategic investments, limit ability to absorb shocks, and raise refinancing risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Sustained operating cash flow (~$6.3B) and robust free cash flow (~$4.4B; ~71% of net income TTM) provide durable internal funding for capex, debt servicing, share actions and reinvestment in omnichannel capabilities, reducing reliance on external financing over the medium term.
Read all positive factors

Loblaw Companies (L) vs. iShares MSCI Canada ETF (EWC)

Loblaw Companies Business Overview & Revenue Model

Company Description
Loblaw Companies Limited is a prominent Canadian enterprise primarily focused on food and pharmacy, delivering a wide array of products and services across the nation. Its diverse business interests encompass grocery, pharmacy, health and beauty, ...
How the Company Makes Money
Loblaw makes money primarily by selling products and services through its retail network and related platforms. (1) Food and everyday merchandise retail: The largest revenue stream comes from selling groceries and consumables (fresh foods, package...

Loblaw Companies Earnings Call Summary

Earnings Call Date:Feb 25, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Jul 23, 2026
Earnings Call Sentiment Positive
The call emphasized consistent, multi-faceted operational progress: steady revenue and EBITDA growth, improving margins, strong e-commerce growth, disciplined capital returns (share buybacks and dividends), successful expansion of discount and health capabilities, automation progress and strategic tech/AI investments. Management acknowledged near-term drags from new store and ramping costs, T&T U.S. investment, category pressures (liquor, tobacco, HABA) and timing uncertainty related to the PC Financial sale and shifted flu season. On balance the company presented multiple clear growth drivers, robust returns, and a plan to continue returning cash to shareholders while managing known short-term headwinds.
Positive Updates
Quarterly and Annual Revenue Growth
Q4 (12-week) revenue grew 3.5% to $15.5 billion; full-year consolidated revenue grew 4.4% to $63.7 billion. On a reported basis (including extra week), revenue grew ~11% in the quarter.
Negative Updates
Pressure in Right-Hand Side Categories
Continued weakness in liquor, tobacco and HABA categories exerted ~20 basis points of pressure on food same-store sales during the quarter.
Read all updates
Q4-2025 Updates
Negative
Quarterly and Annual Revenue Growth
Q4 (12-week) revenue grew 3.5% to $15.5 billion; full-year consolidated revenue grew 4.4% to $63.7 billion. On a reported basis (including extra week), revenue grew ~11% in the quarter.
Read all positive updates
Company Guidance
Loblaw guided that 2026 new‑store investment will be broadly similar to 2025 (roughly ~70 openings versus 77 in 2025), with grocery square footage growth in line with 2025 and drug footprint expected to rise about 3% (with more Shoppers Drug Mart stores); excluding the timing impact of the PC Financial sale and the lapping of the extra 53rd week, management expects the retail business to grow earnings faster than sales and to deliver adjusted EPS growth in the high single digits, plans approximately $2.4 billion of capital expenditures, intends to return most free cash flow to shareholders (targeting roughly $1.9 billion of share buybacks in 2026) and flagged continued same‑store sales momentum into Q1 while noting PC Financial timing and the 53rd week will affect reported results.

Loblaw Companies Financial Statement Overview

Summary
Profitability and cash generation are solid (gross margin ~31%, EBIT margin ~7.1%, improving net margin ~4.3% TTM; operating cash flow ~$6.3B and free cash flow ~$4.4B). The main offset is elevated leverage (debt-to-equity ~1.53x TTM, higher in prior periods) and moderate debt coverage from operating cash flow (~0.46x), which reduces financial flexibility.
Income Statement
78
Positive
Balance Sheet
64
Positive
Cash Flow
74
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue64.25B63.90B61.01B59.53B56.50B53.17B
Gross Profit19.91B19.88B19.73B19.04B17.98B16.73B
EBITDA7.19B7.18B6.90B6.64B6.17B5.80B
Net Income2.76B2.67B2.17B2.10B1.92B1.88B
Balance Sheet
Total Assets41.61B41.58B40.88B38.98B38.15B36.61B
Cash, Cash Equivalents and Short-Term Investments960.00M1.04B2.11B1.95B1.93B2.44B
Total Debt16.73B25.14B19.18B18.17B17.61B16.55B
Total Liabilities30.56B30.39B29.61B27.36B26.69B24.88B
Stockholders Equity10.91B11.03B11.09B11.46B11.30B11.57B
Cash Flow
Free Cash Flow4.43B4.10B3.60B3.58B3.18B3.65B
Operating Cash Flow6.26B5.81B5.80B5.65B4.75B4.83B
Investing Cash Flow-2.02B-1.89B-2.02B-1.84B-2.37B-1.27B
Financing Cash Flow-4.23B-3.99B-3.82B-3.93B-2.75B-3.25B

Loblaw Companies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price61.19
Price Trends
50DMA
62.26
Positive
100DMA
63.18
Positive
200DMA
60.85
Positive
Market Momentum
MACD
0.95
Negative
RSI
57.81
Neutral
STOCH
32.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:L, the sentiment is Positive. The current price of 61.19 is below the 20-day moving average (MA) of 63.46, below the 50-day MA of 62.26, and above the 200-day MA of 60.85, indicating a bullish trend. The MACD of 0.95 indicates Negative momentum. The RSI at 57.81 is Neutral, neither overbought nor oversold. The STOCH value of 32.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:L.

Loblaw Companies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
C$16.55B24.909.98%1.89%-3.40%
71
Outperform
C$50.87B38.2494.71%0.20%16.11%11.08%
70
Outperform
C$19.24B19.2514.38%1.50%3.52%5.04%
66
Neutral
C$75.28B27.4224.88%1.52%4.36%28.73%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
57
Neutral
C$11.50B73.902.98%1.78%2.15%-70.90%
57
Neutral
C$38.84B33.5621.74%1.23%4.36%-0.82%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:L
Loblaw Companies
64.76
9.70
17.61%
TSE:DOL
Dollarama
187.85
0.24
0.13%
TSE:EMP.A
Empire Co Cl A NV
51.25
-3.27
-6.01%
TSE:MRU
Metro Inc.
91.71
-10.25
-10.05%
TSE:SAP
Saputo Inc.
41.31
14.96
56.79%
TSE:WN
George Weston
103.34
15.37
17.47%

Loblaw Companies Corporate Events

Business Operations and StrategyM&A TransactionsRegulatory Filings and Compliance
EQB Wins Competition Bureau Nod for PC Financial Acquisition, Pushing Challenger Bank Strategy Nationwide
Positive
Mar 6, 2026
EQB Inc. and Loblaw Companies Limited said EQB has secured Competition Bureau clearance for its planned acquisition of President’s Choice Bank and related PC Financial entities, a key regulatory step that still requires approvals from the ba...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 05, 2026